16-67942417-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000229.2(LCAT):​c.694T>A​(p.Ser232Thr) variant causes a missense change. The variant allele was found at a frequency of 0.026 in 1,613,908 control chromosomes in the GnomAD database, including 650 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S232A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.017 ( 31 hom., cov: 32)
Exomes 𝑓: 0.027 ( 619 hom. )

Consequence

LCAT
NM_000229.2 missense

Scores

10
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.82

Publications

51 publications found
Variant links:
Genes affected
LCAT (HGNC:6522): (lecithin-cholesterol acyltransferase) This gene encodes the extracellular cholesterol esterifying enzyme, lecithin-cholesterol acyltransferase. The esterification of cholesterol is required for cholesterol transport. Mutations in this gene have been found to cause fish-eye disease as well as LCAT deficiency. [provided by RefSeq, Jul 2008]
LCAT Gene-Disease associations (from GenCC):
  • fish eye disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • LCAT deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Norum disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011052489).
BP6
Variant 16-67942417-A-T is Benign according to our data. Variant chr16-67942417-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 884653.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0173 (2627/152236) while in subpopulation NFE AF = 0.0287 (1952/67990). AF 95% confidence interval is 0.0276. There are 31 homozygotes in GnomAd4. There are 1221 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000229.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LCAT
NM_000229.2
MANE Select
c.694T>Ap.Ser232Thr
missense
Exon 5 of 6NP_000220.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LCAT
ENST00000264005.10
TSL:1 MANE Select
c.694T>Ap.Ser232Thr
missense
Exon 5 of 6ENSP00000264005.5
LCAT
ENST00000570980.1
TSL:2
c.478T>Ap.Ser160Thr
missense
Exon 4 of 5ENSP00000464651.1
LCAT
ENST00000576450.1
TSL:2
c.160T>Ap.Ser54Thr
missense
Exon 1 of 2ENSP00000458141.1

Frequencies

GnomAD3 genomes
AF:
0.0173
AC:
2628
AN:
152118
Hom.:
31
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00493
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.00805
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00641
Gnomad FIN
AF:
0.0271
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.0175
AC:
4389
AN:
251330
AF XY:
0.0175
show subpopulations
Gnomad AFR exome
AF:
0.00486
Gnomad AMR exome
AF:
0.00463
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0276
Gnomad NFE exome
AF:
0.0289
Gnomad OTH exome
AF:
0.0143
GnomAD4 exome
AF:
0.0269
AC:
39307
AN:
1461672
Hom.:
619
Cov.:
33
AF XY:
0.0261
AC XY:
18971
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.00406
AC:
136
AN:
33480
American (AMR)
AF:
0.00456
AC:
204
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000612
AC:
16
AN:
26128
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00645
AC:
556
AN:
86258
European-Finnish (FIN)
AF:
0.0270
AC:
1439
AN:
53248
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.0321
AC:
35743
AN:
1111984
Other (OTH)
AF:
0.0199
AC:
1204
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2493
4986
7479
9972
12465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1352
2704
4056
5408
6760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0173
AC:
2627
AN:
152236
Hom.:
31
Cov.:
32
AF XY:
0.0164
AC XY:
1221
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00491
AC:
204
AN:
41538
American (AMR)
AF:
0.00804
AC:
123
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00642
AC:
31
AN:
4830
European-Finnish (FIN)
AF:
0.0271
AC:
287
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1952
AN:
67990
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
144
289
433
578
722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
29
Bravo
AF:
0.0155
TwinsUK
AF:
0.0291
AC:
108
ALSPAC
AF:
0.0283
AC:
109
ESP6500AA
AF:
0.00660
AC:
29
ESP6500EA
AF:
0.0306
AC:
263
ExAC
AF:
0.0180
AC:
2188
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0235
EpiControl
AF:
0.0228

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 23, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22090275, 24503134)

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

LCAT deficiency Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

LCAT-related disorder Benign:1
Nov 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Norum disease;C0342895:Fish-eye disease Benign:1
May 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
May 22, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Uncertain
0.53
D
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.12
D
MutationAssessor
Benign
2.0
M
PhyloP100
4.8
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.57
Sift
Benign
0.19
T
Sift4G
Uncertain
0.0060
D
Polyphen
0.98
D
Vest4
0.23
MPC
0.53
ClinPred
0.031
T
GERP RS
3.8
PromoterAI
-0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.63
gMVP
0.78
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4986970; hg19: chr16-67976320; COSMIC: COSV107245592; COSMIC: COSV107245592; API